Section 13.12. Examination of materials requirements.

 

(1)  Upon receipt by a facility, each outside shipping container shall be visually examined for identity and to prevent the acceptance of contaminated prescription drugs, or prescription drugs that are otherwise unfit for distribution. This examination shall be adequate to reveal container damage that would suggest possible contamination or other damage to the contents.

(2)  Each outgoing shipment from a facility shall be carefully inspected for identity of the prescription drug and to ensure that there is no delivery of prescription drugs that have been damaged in storage or held under improper conditions.

(3)  The recordkeeping requirements in s. Phar 13.14 shall be followed for all incoming and outgoing prescription drugs at a facility.

History: Cr. Register, July, 1992, No. 439 , eff. 8-1-92; EmR0815 : emerg. am. eff. 6-1-08; CR 08-051 : am. Register November 2008 No. 635 , eff. 12-1-08.